Hypocalcemia: Description:Abnormally low levels of calcium in the circulating blood; commonly denotes subnormal concentrations of calcium ions.Hypocalcemia is frequently encountered in patients who are hospitalized. Presentations vary widely, from asymptomatic to life-threatening situations. A 70-kg person has approximately 1.2 kg of calcium in the body, most of which is stored as hydroxyapatite in bones (>99%). Less than 1% (5-6 g) of this calcium is located in the intracellular and extracellular compartments, with only 1.3 g located extracellularly. The total calcium concentration in the plasma is 4.5-5.1 mEq/L (9-10.2 mg/dL). Fifty percent of plasma calcium is ionized, 40% is bound to proteins (90% of which binds to albumin), and 10% circulates bound to anions (eg, phosphate, carbonate, citrate, lactate, sulfate).Hypocalcemia is less frequent than hypercalcemia. In order of frequency, hypocalcemia occurs in patients with chronic and acute renal failure; vitamin D deficiency; magnesium (Mg) deficiency; acute pancreatitis; hypoparathyroidism and pseudohypoparathyroidism; and infusion of phosphate, citrate, or calcium-free albumin.Symptoms:The most common sign of hypocalcemia is what is called "neuromuscular irritability." Your nerves and muscles, which are directly related to blood calcium levels, may spasm or twitch.
If your blood test results indicate hypocalcemia, you may notice muscle cramps in your legs or your arms.
The symptoms of hypocalcemia you experience may relate to how fast or how slowly the fall in blood calcium levels occur.
If you have long-standing low blood calcium levels, you may notice no symptoms of hypocalcemia.
If you have an "acute" or sudden drop in your blood calcium level, you may notice more twitching.
You may notice, with mildly lowered blood calcium levels, numbness and tingling of your fingers and toes.
You may notice that you are depressed or more irritable if you have mildly low hypocalcemia.
With severely lowered blood calcium levels, you may become confused or disoriented. Your heart muscle may contract irregularly due to the electrolyte disturbance.
Causes and Risk factors:Hypoparathyroidism is the most common cause of hypocalcemia and often develops because of surgery in the central neck requiring radical resection of head and neck cancers. It develops in 1% to 2% of patients after total thyroidectomy. 1 The hypocalcemia may be transient, permanent, or intermittent, as with vitamin D deficiency during the winter. Autoimmune hypoparathyroidism is seen as an isolated defect or as part of polyglandular autoimmune syndrome type I in association with adrenal insufficiency and mucocutaneous candidiasis. Most of these patients have autoantibodies directed against the calcium-sensing receptor. Congenital causes of hypocalcemia include activating mutations of calcium-sensing receptor, which has reset the calcium-parathyroid hormone (PTH) relation to a lower serum calcium level. Mutations affecting intracellular processing of the pre-pro-PTH molecule are also described and lead to hypoparathyroidism, hypocalcemia, or both. Finally, some cases are associated with hypoplasia or aplasia of the parathyroid glands; the best known is DiGeorge syndrome. 2Pseudohypoparathyroidism is a group of disorders with postreceptor resistance to PTH. One classic variant is Albright's hereditary osteodystrophy, associated with low stature, round facies, short digits, and mental retardation. Hypomagnesemia induces PTH resistance and also affects PTH production. Severe hypermagnesemia (>6 mg/dL) can lead to hypocalcemia by inhibiting PTH secretion. Vitamin D deficiency leads to hypocalcemia when associated with decreased dietary calcium intake. The low calcium level stimulates PTH secretion (secondary hyperparathyroidism), leading to hypophosphatemia.Rhabdomyolysis and tumor lysis syndrome cause loss of calcium from the circulation when large amounts of intracellular phosphate are released and precipitate calcium in bone and extraskeletal tissues. A similar mechanism causes hypocalcemia with phosphate administration.Acute pancreatitis precipitates calcium as a soap in the abdomen, causing hypocalcemia. Hungry bone syndrome is hypocalcemia after surgery for hyperparathyroidism (HPT) in patients with severe prolonged disease (secondary or tertiary HPT in renal failure). Serum calcium is rapidly deposited into the bone. Hungry bone syndrome is rarely seen after correction of longstanding metabolic acidosis or after thyroidectomy for hyperthyroidism.Several medications (e.g., ethylenediaminetetraacetic acid [EDTA], citrate present in transfused blood, lactate, foscarnet) chelate calcium in the circulation, sometimes producing hypocalcemia in which ionized calcium is decreased, cohereas total calcium may be normal. Extensive osteoblastic skeletal metastases (prostate and breast cancers) may also cause hypocalcemia. Chemotherapy, including cisplatin, 5-fluorouracil, and leucovorin, causes hypocalcemia mediated through hypomagnesemia. Hypocalcemia after surgery can be mediated by the citrate content of transfused blood or by a large volume of fluid administration and hypoalbuminemia. Patients with sepsis demonstrate hypocalcemia usually associated with hypoalbuminemia.Risk factors for early hypocalcemia include prematurity, being small for gestational age, maternal diabetes, and perinatal asphyxia. Mechanisms vary. Normally, parathyroid hormone helps maintain normal Ca levels when the constant infusion of ionized Ca across the placenta is interrupted at birth. A transient, relative hypoparathyroidism may cause hypocalcemia in preterm and some small-for-gestational-age neonates, who have parathyroid glands that do not yet function adequately; and in infants of mothers with diabetes or hyperparathyroidism, because these women have higher-than-normal ionized Ca levels during pregnancy. Perinatal asphyxia may also increase serum calcitonin, which inhibits Ca release from bone and results in hypocalcemia. In other neonates, the normal phosphaturic renal response to parathyroid hormone is absent; the elevated phosphate (PO4) leads to hypocalcemiaDiagnosis:Hypocalcemia needs confirmation, if there is any doubt, by measurement of the serum ionized calcium level. When the diagnosis is confirmed by the finding of a serum calcium level lower than 8.2 mg/dL (2.05 mmol/L) or an ionized calcium level lower than 4.4 mg/dL (1.1 mmol/L), attention should turn toward seeking the cause.Medical history can establish cause in patients with postsurgical hypoparathyroidism or chronic renal insufficiency, or who have been given phosphate. Laboratory evaluation should be guided by history and physical examination. Renal failure, cell lysis syndromes, hypomagnesemia or hypermagnesemia, and acute pancreatitis can be diagnosed or excluded using measurements of serum creatinine, creatine kinase, magnesium, and amylase levels. A serum magnesium concentration lower than 1.0 mg/dL should be considered significant and corrected. In the absence of these conditions, disorders affecting the production or action of PTH or vitamin D should be considered. The immunoreactive PTH (iPTH), 25-hydroxyvitamin D, and 1,25-hydroxyvitaminvitamin D levels need to be determined; results are often delayed 2 to 7 days.The serum phosphate level can help delineate causes of hypocalcemia. Low phosphate levels signify excess PTH activity (secondary HPT) or low dietary phosphate intake. High phosphate levels in the absence of tissue breakdown or renal failure signify hypoparathyroidism or pseudohypoparathyroidism.Interpretation of the iPTH level requires simultaneous serum calcium determination. A low or even normal iPTH level associated with hypocalcemia is a powerful sign of hypoparathyroidism. iPTH, immunoreactive parathyroid hormone.Measurements of 25-hydroxyvitamin D are more informative in most patients with hypocalcemia than measurements of 1, 25-hydroxyvitamin D. This is because vitamin D deficiency causes hypocalcemia and stimulates PTH secretion, which in turn stimulates renal conversion of 25-hydroxyvitamin D to 1,25-hydroxyvitamin D. Low dietary intake, poor absorption of vitamin D, and lack of production in the skin results in a low serum 25-hydroxyvitamin D level. The 25-hydroxyvitamin D level is also low in patients taking phenytoin, those suffering from nephrotic syndrome (loss of vitamin D-binding protein), and patients with hepatobiliary disease. The 1,25-hydroxyvitamin D level will be low despite a normal or high 25-hydroxyvitamin D level in patients with renal insufficiency, patients with deficiency of renal 1a-hydroxylase (vitamin D-dependent rickets, type 1), and patients with hypoparathyroidism. High levels of 1,25-hydroxyvitamin D are seen in hereditary vitamin D-resistant rickets (formerly called vitamin D-resistant rickets, type 2).Treatment:Patients with acute symptomatic hypocalcemia (calcium level lower than 7.0 mg/dL, ionized calcium level lower than 0.8 mmol/L) should be treated promptly with IV calcium. Calcium gluconate is preferred over calcium chloride because it causes less tissue necrosis if extravasated. The first 100 to 200 mg of elemental calcium (1 to 2 g calcium gluconate) should be given over 10 to 20 minutes. Faster administration may result in cardiac dysfunction, even arrest. This should be followed by a slow calcium infusion, at 0.5 to 1.5 mg/kg/hr. Calcium infusion should continue until the patient is receiving effective doses of oral calcium and vitamin D. Calcium for infusion should be diluted in saline or dextrose solution to avoid vein irritation. The infusion should not contain bicarbonate or phosphate because this can form an insoluble calcium salt. If bicarbonate or phosphate administration is necessary, a separate IV line should be used.Coexisting hypomagnesemia should be corrected in every patient. Care should be taken in patients with renal insufficiency because they cannot excrete excess magnesium. Magnesium is given via infusion and initiated with 2 g magnesium sulfate over 10 to 15 minutes, followed by 1 g/hr. 3 In patients with severe hyperphosphatemia (tumor lysis syndrome, rhabdomyolysis, or chronic renal failure), treatment is focused on correcting the hyperphosphatemia.Acute hyperphosphatemia usually resolves in patients with intact renal function. Phosphate excretion may be aided by saline infusion (caution—this can lead to worsening of hypocalcemia), and acetazolamide, a carbonic anhydrase inhibitor, 10 to 15 mg/kg every 3 to 4 hours. Hemodialysis may be necessary for patients with symptomatic hypocalcemia and hyperphosphatemia, especially if renal function is impaired. Chronic hyperphosphatemia is managed by a low-phosphate diet and use of phosphate binders with meals.Chronic hypocalcemia (hypoparathyroidism) is treated by oral calcium administration and, if this is insufficient, vitamin D supplementation. The serum calcium level should be targeted to about 8.0 mg/dL. Most patients will be entirely asymptomatic at this level, and further elevation will lead to hypercalciuria because of the lack of PTH effect on the renal tubules. Chronic hypercalciuria carries the risks of nephrocalcinosis, nephrolithiasis, and renal impairment.Several oral calcium preparations are available (Box 2 ). Calcium carbonate is the cheapest form but may be poorly absorbed, especially in older patients and those with achlorhydria. Similarly, various forms of vitamin D are available.Special consideration is necessary for the treatment of women with hypoparathyroidism during pregnancy and nursing. Vitamin D requirements increase gradually during pregnancy and may reach three times prepregnancy needs. Supplementation doses of vitamin D should be titrated using frequent serum calcium level measurements. After delivery, if there is no plan to nurse, the dose could be decreased to the prepregnancy level. If the baby is to be nursed, the dose of calcitriol should be decreased to 50% of the prepregnancy dose, 4 because endogenous calcitriol production is stimulated by prolactin and increased production of PTH-related peptide, which is also stimulated by prolactin).Medicine and medications:Oral Calcium Preparations.
Vitamin D Preparations.
Calcitriol (Rocaltrol; Calcijex).
Calcifediol (Calderol; requires activation in the kidneys).
Ergocalciferol (vitamin D2, Drisdol).
DISCLAIMER: This information should not substitute for seeking responsible, professional medical care.
According to the findings of a recent research, published in the JNeurosci, regular talking to young children associated with the stronger connections between two developing brain regions critical for language. The research was held independently of parental income...
A recent study, conducted by the researchers from Kagoshima University in Japan, suggests that compounds found in Sakurajima radish, or Sakurajima daikon, can be effective in the fight against cardiovascular disease. For the research, the team used vascular...
A new study of nearly 18,000 participants found that those with high fitness at middle age were significantly less likely to die from heart disease in later life, even if they were diagnosed with depression. Doctor's Tips: How to Stay Fit While Treating Depression Dr....
The warm ups are supposed to increase body temperature and blood flow so the muscles and surrounding joints become more responsive and prepared for physical activity. Although there’s a neurological element to warm-ups, most research focuses on the physiological...
We all know that doing sports is very important, both for health and for a beautiful body. But at the moment when we decide to finally take the path, we are faced with the question: what kind of sport is right for me? So, let's start with the fact that a lot of people...